| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6487454 | Current Opinion in Biotechnology | 2016 | 4 Pages |
Abstract
- Translational challenges impact the growth rate of commercially available biomaterial-based therapies.
- The understanding of the pertinent regulatory challenges is key in successful biomaterial translation.
- A pragmatic product development approach might enhance translational success.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
Monica Andrea Serban,